Showing 20 of 90 recruiting trials for “hereditary-attr-amyloidosis”
RecruitingNCT06129656 ↗
Cardiac Amyloidosis Registry of University Hospital Leipzig
RecruitingNCT06383143 ↗
Promoting Diagnosis and Management of AL in Italy (ProDigALIty)
Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis
Daratumumab for Patients With Light Chain Amyloidosis
RecruitingNCT05760287 ↗
Echocardiographic Characterization of Cardiac Amyloidosis
🏥 Fondazione Policlinico Universitario Agostino Gemelli IRCCS📍 1 site📅 Started Dec 2022View details ↗
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
👨⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 29 sites📅 Started Nov 2022View details ↗
RecruitingNCT05489549 ↗
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
RecruitingNCT05593679 ↗
A Multi-center Cardiac PYP Scan Registry in Taiwan
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis
Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis
👨⚕️ Michael A Rosenzweig, City of Hope Comprehensive Cancer Center LAO📍 16 sites📅 Started Aug 2022View details ↗
RecruitingNCT05379101 ↗
Intracardiac Flow Assessment in Cardiac Amyloidosis
Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
RecruitingNCT04850105 ↗
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
RecruitingNCT05283993 ↗
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
Analysis of the Evolution of SUVmax by Quantitative Analysis Method of Bisphosphonate Scintigraphy
Prevalence and Significance of ATTR Aortic Valve Amyloidosis in Degenerative Aortic Stenosis
RecruitingNCT04561518 ↗
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →